I was part of the team working on the KATY project at the University of Zaragoza. We used our expertise in network and systems biology to predict cellular and network perturbations from transcriptomic data, and to integrate network methodologies with AI techniques.

KATY was funded by the European Union to build an AI-empowered personalised medicine system, putting easily-interpretable AI data at clinicians’ and researchers’ fingertips. As a stress test, the project initially focused on patients diagnosed with a rare and complex form of kidney cancer.